Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A study of renal and bone biomarkers in HIV-exposed uninfected neonates suggested that third-trimester TDF exposure was associated with increased urinary phosphate loss and lower vitamin D levels, although no significant effect on markers of bone resorption was observed, indicating a limited short-term impact on bone turnover (14).

Source: Foetal and neonatal bone mineralisation and growth. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Scoping review.

Scoping review

Maps the extent and characteristics of research on a topic.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies

Scoping review · Frontiers in Endocrinology · 2026

Original publication title

In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies

Xia Ji; Yuanzhong Wang; Zefan Zhang; Kok-Lun Pang; Xiong Khee Cheong; Norliza Muhammad; Kok-Yong Chin

Copyright © 2026 Ji, Wang, Zhang, Pang, Cheong, Muhammad and Chin.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In utero and lactational exposure to TDF had minimal impact on paediatric bone development but was consistently linked to maternal bone loss and incomplete skeletal recovery. While the benefits of TDF in preventing vertical transmission of HIV and HBV outweigh these risks, the findings highlight the importance of ongoing monitoring of maternal bone health.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This scoping review synthesised evidence on the impact of in utero and lactational TDF exposure on bone health in offspring and mothers.

Source: Objective

Abstract: What methods does the paper describe?

A systematic search of PubMed, Scopus, Web of Science and the China National Knowledge Infrastructure identified randomised controlled trials, cohort studies, and observational studies assessing bone mineral density, bone mineral content, growth, or bone turnover markers in relation to perinatal TDF exposure. Thirty-one studies met the inclusion criteria.

Source: Methods

Abstract: Results

Most studies reported no clinically significant long-term effects of TDF on paediatric bone mineralisation, growth, or metabolism from infancy to mid-childhood. A transient reduction in neonatal bone mineral content was noted in a few studies, but its clinical relevance appeared limited. In contrast, TDF use in mothers was consistently associated with accentuated bone loss during pregnancy and lactation, particularly at the hip, with incomplete recovery postpartum, indicating potential long-term skeletal risk.

Source: Results

Abstract: Conclusions

In utero and lactational exposure to TDF had minimal impact on paediatric bone development but was consistently linked to maternal bone loss and incomplete skeletal recovery. While the benefits of TDF in preventing vertical transmission of HIV and HBV outweigh these risks, the findings highlight the importance of ongoing monitoring of maternal bone health.

Source: Conclusions
Authors’ abstract

Introduction

Tenofovir disoproxil fumarate (TDF) is a key antiretroviral agent for preventing mother-to-child transmission of human immunodeficiency virus (HIV) and treating chronic hepatitis B (HBV) during pregnancy. However, concerns persist regarding its potential effects on bone metabolism during foetal development and postpartum recovery.

Objective

This scoping review synthesised evidence on the impact of in utero and lactational TDF exposure on bone health in offspring and mothers.

Methods

A systematic search of PubMed, Scopus, Web of Science and the China National Knowledge Infrastructure identified randomised controlled trials, cohort studies, and observational studies assessing bone mineral density, bone mineral content, growth, or bone turnover markers in relation to perinatal TDF exposure. Thirty-one studies met the inclusion criteria.

Results

Most studies reported no clinically significant long-term effects of TDF on paediatric bone mineralisation, growth, or metabolism from infancy to mid-childhood. A transient reduction in neonatal bone mineral content was noted in a few studies, but its clinical relevance appeared limited. In contrast, TDF use in mothers was consistently associated with accentuated bone loss during pregnancy and lactation, particularly at the hip, with incomplete recovery postpartum, indicating potential long-term skeletal risk.

Conclusions

In utero and lactational exposure to TDF had minimal impact on paediatric bone development but was consistently linked to maternal bone loss and incomplete skeletal recovery. While the benefits of TDF in preventing vertical transmission of HIV and HBV outweigh these risks, the findings highlight the importance of ongoing monitoring of maternal bone health.

Publication and source details

Original title: In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies

Xia Ji; Yuanzhong Wang; Zefan Zhang; Kok-Lun Pang; Xiong Khee Cheong; Norliza Muhammad; Kok-Yong Chin

Frontiers in Endocrinology · 2026

* Correspondence: Xiong Khee Cheong, cheongxk@gmail.com; Kok-Yong Chin, chinky@ukm.edu.myCopyright © 2026 Ji, Wang, Zhang, Pang, Cheong, Muhammad and Chin.2026Ji, Wang, Zhang, Pang, Cheong, Muhammad and Chinhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Universiti Kebangsaan Malaysia10.13039/501100004515 The author(s) declared that financial support was received for this work and/or its publication. The researchers are supported by Universiti Kebangsaan Malaysia via the Fundamental Research Grant (FF-2025-366), Baotou Municipal Health and Medical Science and Technology Project (2023wsjkkj82) and the Science and Technology Youth Project of the Joint Research Fund for Public Hospitals (2024GLLH0623).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:44:29.038017+00:00

DOI: 10.3389/fendo.2026.1798685 · PMC13581578